Literature DB >> 5116230

Metabolism of [14C]verapamil.

H M McIlhenny.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5116230     DOI: 10.1021/jm00294a010

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  10 in total

Review 1.  Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore.

Authors:  Fraser F Fleming; Lihua Yao; P C Ravikumar; Lee Funk; Brian C Shook
Journal:  J Med Chem       Date:  2010-08-30       Impact factor: 7.446

Review 2.  [Drug metabolism studies using mass spectrometry].

Authors:  G Spiteller; G Remberg
Journal:  Naturwissenschaften       Date:  1974-11

3.  Enantioselective kinetics of verapamil and norverapamil in isolated perfused rat livers.

Authors:  R Mehvar; J M Reynolds; M A Robinson; J A Longstreth
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

4.  The effect of oral verapamil therapy on antipyrine clearance.

Authors:  D O Rumiantsev; V K Piotrovskii; O S Riabokon; I D Slastnikova; E V Kokurina; V I Metelitsa
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

Review 5.  Verapamil: a review of its pharmacological properties and therapeutic use.

Authors:  B N Singh; G Ellrodt; C T Peter
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546

Review 6.  Clinical pharmacokinetics of verapamil.

Authors:  S R Hamann; R A Blouin; R G McAllister
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

7.  Metabolism of propafenone and verapamil by cryopreserved human, rat, mouse and dog hepatocytes: comparison with metabolism in vivo.

Authors:  B Reder-Hilz; M Ullrich; M Ringel; N Hewitt; D Utesch; F Oesch; J G Hengstler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-03-04       Impact factor: 3.000

8.  Metabolism of verapamil in a family pedigree with deficient N-oxidation of trimethylamine.

Authors:  R Ayesh; H Kroemer; M Eichelbaum; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

9.  Transformation of verapamil by Cunninghamella blakesleeana.

Authors:  Lu Sun; Hai-Hua Huang; Lei Liu; Da-Fang Zhong
Journal:  Appl Environ Microbiol       Date:  2004-05       Impact factor: 4.792

10.  A combined accelerator mass spectrometry-positron emission tomography human microdose study with 14C- and 11C-labelled verapamil.

Authors:  Claudia C Wagner; Marie Simpson; Markus Zeitlinger; Martin Bauer; Rudolf Karch; Aiman Abrahim; Thomas Feurstein; Matthias Schütz; Kurt Kletter; Markus Müller; Graham Lappin; Oliver Langer
Journal:  Clin Pharmacokinet       Date:  2011-02       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.